tradingkey.logo

Albemarle Corp

ALB
140.475USD
+5.765+4.28%
Close 12/18, 16:00ETQuotes delayed by 15 min
16.53BMarket Cap
LossP/E TTM

Albemarle Corp

140.475
+5.765+4.28%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Albemarle Corp

Currency: USD Updated: 2025-12-17

Key Insights

Albemarle Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 17/70 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 112.67.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Albemarle Corp's Score

Industry at a Glance

Industry Ranking
17 / 70
Overall Ranking
109 / 4587
Industry
Chemicals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 27 analysts
Hold
Current Rating
112.669
Target Price
-11.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Albemarle Corp Highlights

StrengthsRisks
Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). It serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Overvalued
The company’s latest PB is 2.04, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 112.98M shares, increasing 0.39% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.30K shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-17

The current financial score of Albemarle Corp is 7.67, ranking 26/70 in the Chemicals industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.31B, representing a year-over-year decrease of 3.46%, while its net profit experienced a year-over-year decrease of 81.78%.

Score

Industry at a Glance

Previous score
7.67
Change
0

Financials

9.89

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

5.05

Operational Efficiency

8.41

Growth Potential

6.56

Shareholder Returns

8.43

Albemarle Corp's Company Valuation

Currency: USD Updated: 2025-12-17

The current valuation score of Albemarle Corp is 7.78, ranking 34/70 in the Chemicals industry. Its current P/E ratio is -84.42, which is -157.95% below the recent high of 48.92 and 0.00% above the recent low of -84.42.

Score

Industry at a Glance

Previous score
7.78
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 17/70
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-17

The current earnings forecast score of Albemarle Corp is 6.67, ranking 46/70 in the Chemicals industry. The average price target for Albemarle Corp is 110.00, with a high of 185.00 and a low of 58.00.

Score

Industry at a Glance

Previous score
6.67
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 27 analysts
Hold
Current Rating
112.669
Target Price
-11.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

23
Total
5
Median
7
Average
Company name
Ratings
Analysts
Albemarle Corp
ALB
27
Ecolab Inc
ECL
27
Eastman Chemical Co
EMN
19
Celanese Corp
CE
18
Sociedad Quimica y Minera de Chile SA
SQM
16
Element Solutions Inc
ESI
12
1
2
3
4
5

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-17

The current price momentum score of Albemarle Corp is 9.21, ranking 11/70 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 145.41 and the support level at 117.30, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.85
Change
0.36

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.663
Neutral
RSI(14)
66.112
Neutral
STOCH(KDJ)(9,3,3)
76.303
Neutral
ATR(14)
5.365
High Vlolatility
CCI(14)
135.294
Buy
Williams %R
18.876
Overbought
TRIX(12,20)
0.883
Sell
StochRSI(14)
60.251
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
133.066
Buy
MA10
129.936
Buy
MA20
126.964
Buy
MA50
110.333
Buy
MA100
94.991
Buy
MA200
79.998
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-17

The current institutional shareholding score of Albemarle Corp is 10.00, ranking 1/70 in the Chemicals industry. The latest institutional shareholding proportion is 106.58%, representing a quarter-over-quarter decrease of 1.62%. The largest institutional shareholder is The Vanguard, holding a total of 14.58M shares, representing 12.38% of shares outstanding, with 0.36% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
14.70M
+0.52%
Capital World Investors
8.24M
-17.32%
BlackRock Institutional Trust Company, N.A.
6.35M
+2.05%
State Street Investment Management (US)
6.64M
+3.35%
PRIMECAP Management Company
Star Investors
3.31M
-0.79%
Geode Capital Management, L.L.C.
2.95M
+2.04%
Franklin Advisers, Inc.
4.54M
+28.97%
BofA Global Research (US)
1.74M
+24.94%
Invesco Capital Management LLC
Star Investors
2.58M
+10.77%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-17

The current risk assessment score of Albemarle Corp is 5.30, ranking 43/70 in the Chemicals industry. The company's beta value is 1.42. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.30
Change
0
Beta vs S&P 500 index
1.41
VaR
+5.35%
240-Day Maximum Drawdown
+47.93%
240-Day Volatility
+62.49%

Return

Best Daily Return
60 days
+8.50%
120 days
+8.50%
5 years
+19.13%
Worst Daily Return
60 days
-8.91%
120 days
-11.49%
5 years
-19.91%
Sharpe Ratio
60 days
+3.72
120 days
+2.75
5 years
+0.25

Risk Assessment

Maximum Drawdown
240 days
+47.93%
3 years
+82.33%
5 years
+84.40%
Return-to-Drawdown Ratio
240 days
+1.21
3 years
-0.21
5 years
-0.03
Skewness
240 days
-0.00
3 years
-0.01
5 years
-0.19

Volatility

Realised Volatility
240 days
+62.49%
5 years
+52.65%
Standardised True Range
240 days
+3.16%
5 years
+5.45%
Downside Risk-Adjusted Return
120 days
+382.53%
240 days
+382.53%
Maximum Daily Upside Volatility
60 days
+52.05%
Maximum Daily Downside Volatility
60 days
+50.03%

Liquidity

Average Turnover Rate
60 days
+3.68%
120 days
+3.30%
5 years
--
Turnover Deviation
20 days
+31.01%
60 days
+38.08%
120 days
+23.89%

Peer Comparison

Chemicals
Albemarle Corp
Albemarle Corp
ALB
7.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Linde PLC
Linde PLC
LIN
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ecovyst Inc
Ecovyst Inc
ECVT
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF Industries Holdings Inc
CF
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cabot Corp
Cabot Corp
CBT
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Innospec Inc
Innospec Inc
IOSP
8.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Albemarle Corp?

The TradingKey Stock Score provides a comprehensive assessment of Albemarle Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Albemarle Corp’s performance and outlook.

How do we generate the financial health score of Albemarle Corp?

To generate the financial health score of Albemarle Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Albemarle Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Albemarle Corp.

How do we generate the company valuation score of Albemarle Corp?

To generate the company valuation score of Albemarle Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Albemarle Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Albemarle Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Albemarle Corp.

How do we generate the earnings forecast score of Albemarle Corp?

To calculate the earnings forecast score of Albemarle Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Albemarle Corp’s future.

How do we generate the price momentum score of Albemarle Corp?

When generating the price momentum score for Albemarle Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Albemarle Corp’s prices. A higher score indicates a more stable short-term price trend for Albemarle Corp.

How do we generate the institutional confidence score of Albemarle Corp?

To generate the institutional confidence score of Albemarle Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Albemarle Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Albemarle Corp.

How do we generate the risk management score of Albemarle Corp?

To assess the risk management score of Albemarle Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Albemarle Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Albemarle Corp.
KeyAI